Howard M Shulman
Overview
Explore the profile of Howard M Shulman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
948
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khimani F, McDonald G, Shulman H, Betts B, Locke F, Fernandez H, et al.
Bone Marrow Transplant
. 2018 Jun;
54(1):85-89.
PMID: 29895929
Sirolimus-based graft vs. host disease (GVHD) prophylaxis is associated with higher incidence of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after allogeneic hematopoietic cell transplantation (HCT). However, whether the clinical manifestations and...
2.
Myerson D, Steinbach G, Gooley T, Shulman H
Biol Blood Marrow Transplant
. 2017 May;
23(9):1573-1579.
PMID: 28533059
The pathologic interpretation of gut biopsies in hematopoietic cell transplant recipients to assess graft-versus-host disease (GVHD) is well accepted and supplements clinical and endoscopic findings. However, the histologic activity grading...
3.
Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, et al.
Clin Cancer Res
. 2015 Sep;
22(2):319-27.
PMID: 26378033
Purpose: Cutaneous sclerosis occurs in 20% of patients with chronic graft-versus-host disease (GVHD) and can compromise mobility and quality of life. Experimental Design: We conducted a prospective, multicenter, randomized, two-arm...
4.
Kreft A, Mottok A, Mesteri I, Cardona D, Janin A, Kuhl A, et al.
Virchows Arch
. 2015 Jul;
467(3):255-63.
PMID: 26164839
Graft versus host disease (GvHD) is a clinically important complication after allogeneic hematopoietic stem cell transplantation (HSCT). Its diagnosis relies on clinical and histopathological findings. In order to evaluate and...
5.
Shulman H, Cardona D, Greenson J, Hingorani S, Horn T, Huber E, et al.
Biol Blood Marrow Transplant
. 2015 Feb;
21(4):589-603.
PMID: 25639770
The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus...
6.
Evans A, Loeb K, Shulman H, Hassan S, Qiu W, Hockenbery D, et al.
Am J Surg Pathol
. 2014 Dec;
39(2):212-20.
PMID: 25517948
Development of liver disease after hematopoietic cell transplantation is common and the causes diverse. Infection by hepatitis C virus (HCV) can be seen in patients who are chronically infected before...
7.
Shulman H, Cooper K, Devine W, Trzeciak M, Burney U, Chan W, et al.
J Am Osteopath Assoc
. 2014 Apr;
114(5):336-9.
PMID: 24777996
No abstract available.
8.
Milano F, Shulman H, Guthrie K, Riffkin I, McDonald G, Delaney C
Biol Blood Marrow Transplant
. 2014 Apr;
20(7):1008-13.
PMID: 24704386
Cord colitis syndrome after umbilical cord blood transplantation (UCBT) involves late-onset diarrhea, absence of infection or GVHD, chronic active colitis, and granulomatous inflammation that responds to antibiotics. We tested the...
9.
Stift J, Baba H, Huber E, Federmann B, Fischer H, Schmitt-Graeff A, et al.
Virchows Arch
. 2014 Jan;
464(2):175-90.
PMID: 24385287
After allogeneic hematopoietic cell transplantation (alloHCT) liver biopsy is performed for enigmatic liver disorders when noninvasive diagnostic steps have failed in establishing a definitive diagnosis. This document provides an updated...
10.
Deeg H, Scott B, Fang M, Shulman H, Gyurkocza B, Myerson D, et al.
Blood
. 2012 Jul;
120(7):1398-408.
PMID: 22767498
Clonal cytogenetic abnormalities are a major risk factor for relapse after hematopoietic cell transplantation (HCT) for myelodysplastic syndrome (MDS). We determined the impact of the recently established 5-group cytogenetic classification...